Christopher Heery
Chief Tech/Sci/R&D Officer at ARCELLX, INC.
Net worth: 459 234 $ as of 2024-04-29
Profile
Christopher R.
Heery is currently the Chief Medical Officer at Arcellx, Inc. Prior to this, he was the Chief Medical Officer at Precision BioSciences, Inc. from 2019 to 2021.
He also held the position of Chief Medical Officer at Bavarian Nordic A and was the Head-Clinical Trials at the National Cancer Institute.
Heery received his undergraduate degree from Duke University and his doctorate from Brody School of Medicine in 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARCELLX, INC.
0.02% | 2024-04-30 | 8,938 ( 0.02% ) | 459 234 $ | 2024-04-29 |
Christopher Heery active positions
| Companies | Position | Start |
|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 2021-03-31 |
Former positions of Christopher Heery
| Companies | Position | End |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2021-04-22 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | - |
Training of Christopher Heery
| Brody School of Medicine | Doctorate Degree |
| Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| BAVARIAN NORDIC A/S | Health Technology |
| PRECISION BIOSCIENCES, INC. | Health Technology |
| ARCELLX, INC. | Health Technology |
| Private companies | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Stock Market
- Insiders
- Christopher Heery
